Newborn Acquisition Corp.

Newborn Acquisition Corp., trading under the ticker NBAC, was a blank-check company that completed its initial public offering in 2020 and targeted the healthcare and life sciences sector. The company filed a Definitive Proxy Statement on Merger or Acquisition, form DEFM14A, with the SEC on February 17, 2021, indicating it had reached the shareholder-vote stage of its proposed business combination. The DEFM14A filing, bearing accession number 0001213900-21-010057, represents a key milestone in the SPAC lifecycle, requiring stockholder approval before a transaction can close. NBAC's progression to a definitive proxy reflected the active SPAC deal environment that characterized early 2021. Visit SpacDesk and sign up for full access to NBAC's filing history, deal timeline, and sponsor data.